High materiality8/10
Relay Therapeutics price target raised to $31 from $22 at Goldman Sachs
Why it may matterVerify against the original reporting
Bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Goldman Sachs raises RLAY target to $31 from $22; current price $19.18.
- Goldman Sachs raises RLAY target to $31 from $22; price $19.18.
Key facts
- 01
Target: $31
- 02
Posted price: $19.18
- 03
Analyst firm: Goldman Sachs
- 04
Analyst: Salveen Richter
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.